The Current Ratio as of December 2025 (TTM) for SynAct Pharma AB (SYNACT.ST) is 3.28

According to SynAct Pharma AB’s latest financial reports and current stock price. The company's current Current Ratio is 3.28. This represents a change of -25.88% compared to the average of 4.42 of the last 4 quarters.

SynAct Pharma AB (SYNACT.ST) Historical Current Ratio (quarterly & annually)

How has SYNACT.ST Current Ratio performed in the past?

The mean historical Current Ratio of SynAct Pharma AB over the last ten years is 4.20. The current 3.28 Current Ratio has changed 7.71% with respect to the historical average. Over the past ten years (40 quarters), SYNACT.ST's Current Ratio was at its highest in in the September 2016 quarter at 39.79. The Current Ratio was at its lowest in in the September 2019 quarter at 0.65.

SynAct Pharma AB (SYNACT.ST) Current Ratio by Quarter and Year

Discovering the peaks and valleys of SynAct Pharma AB Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

SynAct Pharma AB (SYNACT.ST) Average Current Ratio

How has SYNACT.ST Current Ratio performed in the past?

The current Current Ratio of SynAct Pharma AB (SYNACT.ST) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

SynAct Pharma AB (SYNACT.ST) Current Ratio vs. Peers

How is SYNACT.ST’s Current Ratio compared to its peers?

SynAct Pharma AB’s Current Ratio is less than Oncopeptides AB (publ) (3.42), less than Xspray Pharma AB (publ) (6.72), less than I-Tech AB (7.67), greater than Infant Bacterial Therapeutics AB (publ) (3.15), less than Diamyd Medical AB (publ) (10.64), less than Genovis AB (publ.) (10.78), greater than Orexo AB (publ) (1.43), less than Sedana Medical AB (publ) (4.16), less than Cantargia AB (publ) (5.82), less than C-Rad AB (publ) (3.35),

Build a custom stock screener for SynAct Pharma AB (SYNACT.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SynAct Pharma AB using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

SynAct Pharma AB (SYNACT.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like SynAct Pharma AB or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.